$CNXC

Caldwell Christopher A purchased $21K of CNXC

Caldwell Christopher A (President and CEO) purchased 1,000 shares of Concentrix Corp (CNXC) at $21.25 on 2026-07-08.

Original reporting
SEC EDGAR · Caldwell Christopher A
Published Jul 9, 2026, 10:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 10:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CNXC
Bullish
medium confidence
Mentioned
$CNXC
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CNXCBullishLow
01

Why it matters

Traders may treat the CEO purchase as a modest positive sentiment input, but it does not provide new operational, financial, or regulatory information.

02

Market read

A primary-source insider buy is newly disclosed, but the transaction size suggests limited impact on valuation or near-term trading flows.

03

What to watch

No 10b5-1 plan is disclosed, but the filing does not provide intent, timing constraints, or whether the purchase is part of a broader pattern.

Relevance 4/10Novelty 5/10Timing: Form 4 filed 2026-07-09, covering a 2026-07-08 insider purchase.

Background

The article is a SEC Form 4 insider transaction disclosure for Concentrix (CNXC) by its President and CEO.

Company-level read

Ticker impact

$CNXCBullishMedium confidence
Context

Concentrix CEO bought 1,000 shares on 2026-07-08 at $21.2497, per Form 4 filed 2026-07-09, with no 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades unless followed by additional disclosures.

Evidence & confidence

Form 4 provides a primary-source transaction, but the disclosed size ($21.25k) is small relative to company scale and the filing includes no 10b5-1 plan, which may increase interpretive attention without changing fundamentals.

Market effects

Minimal; insider purchase does not materially change the broader IT services/outsourcing read-through.

None indicated.

None indicated.

Counterpoint

Insider open-market buys can be routine liquidity or diversification-related, and the small dollar amount reduces signal strength.

Key entities

  • Concentrix Corp

    Subject of the Form 4 insider transaction disclosure.

  • Caldwell Christopher A

    President and CEO who purchased 1,000 shares open-market at $21.2497 on 2026-07-08.

Related articles

$CNXCHighAI 9/10

Why Concentrix (CNXC) Shares Are Getting Obliterated Today

Concentrix (CNXC) shares fell about 8% after the company reported Q2 fiscal 2026 results and cut guidance. Adjusted EPS was $2.63, below estimates. Q3 EPS guidance was $2.65–$2.77 versus $3.08 consensus, and full-year EPS was lowered to $10.83–$11.18 from $11.48–$12.07, citing offshoring, demand variability, and $175 million restructuring charges.

$CNXCMedAI 8/10

Concentrix (CNXC) Securities Fraud Investigation - Levi & Korsinsky

Levi & Korsinsky says Concentrix (NASDAQ: CNXC) shareholders lost about 20% after the company reported Q2 2026 results below consensus on revenue and EPS and cut full-year 2026 guidance. Revenue guidance was lowered to $9.93-$10.03 billion from $10.11 billion midpoint, and non-GAAP EPS to $10.83-$11.18 from $11.48-$12.07, citing off-shoring headwinds.

$CNXCMedAI 8/10

Call centre stocks fall on fear AI makes them ‘uninvestible’

Concentrix Corp. and Teleperformance SE fell sharply after Concentrix cut its fiscal 2026 revenue outlook midpoint by about US$130 million and warned some customers are reducing customer-support spending. Executives said clients may move work offshore or drop support in high-cost markets. Analysts cited AI tools as a threat to demand; Concentrix fell up to 24% and Teleperformance up to 16%.

$CNXCMed

Why Is Concentrix Stock Falling Tuesday? - Concentrix (NASDAQ:CNXC)

Concentrix (CNXC) shares fell after a guidance reset. Canaccord said fiscal 2026 constant-currency revenue growth was cut to ~0.75% from ~2.5%, citing structural customer spending headwinds including offshoring and cuts. It expects iX AI platform ARR to exceed $120M by year-end, but said it’s too small to offset weakness. Canaccord kept a Buy and noted strong margins, record Q2 free cash flow, and net leverage <2.6x.

$CNXCMed

Concentrix Corp (CNXC) Q2 2026 Earnings Call Highlights: Record Cash Flow and Strategic

Concentrix (CNXC) reported Q2 2026 earnings call updates: CEO Christopher Caldwell said full-year headwinds stem from offshoring rising to 3% (from 2%) and about 1% from client reprioritization in high-cost markets; effects are expected to be gross-profit neutral over the medium term. CFO Andre Valentine cited lower revenue and duplicate costs for reduced operating margin guidance, with margin improvement expected in H2 via restructuring and iX Suite scaling. iX Suite now influences 11% of reven